Navana Pharmaceuticals PLC (DSE:NAVANAPHAR)
61.80
-0.80 (-1.28%)
At close: Oct 15, 2026
| Market Cap | 6.64B +14.7% |
| Revenue (ttm) | 10.57B +24.8% |
| Net Income | 606.13M +35.3% |
| EPS | 5.60 +34.4% |
| Shares Out | 107.42M |
| PE Ratio | 11.17 |
| Forward PE | n/a |
| Dividend | 1.40 (2.27%) |
| Ex-Dividend Date | Nov 20, 2025 |
| Volume | 260,435 |
| Open | n/a |
| Previous Close | 62.60 |
| Day's Range | 61.60 - 63.30 |
| 52-Week Range | 45.50 - 78.00 |
| Beta | 0.19 |
| Analysts | n/a |
| Price Target | n/a |
| Est. Earnings | Oct 28, 2026 |